MedTrace Logo

Perioperative Virtual Reality Intervention for Pain and Anxiety During Vasectomies

NCT07055178 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-05-05

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a virtual reality (VR) program (TRIPP) can reduce pain, anxiety, and distress in adult men (aged 18+) undergoing a vasectomy under local anesthesia. The main questions it aims to answer are:

* Does using VR during a vasectomy lower patients' pain during the procedure compared to standard care?
* Does VR reduce anxiety and distress compared to standard care?
* Are patients more satisfied with their experience when using VR compared to standard care?

Researchers will compare two groups:

* VR group: Patients will use a VR headset with a guided meditation program (TRIPP) during their vasectomy.
* Control group: Patients will receive standard care (no VR).

Participants will:

* Be randomly assigned to either the VR group or control group.
* Complete brief questionnaires before, during, and after the procedure (about 15-20 minutes each time).
* (VR group only) Use a VR headset during the procedure and provide optional feedback about the experience.

Why is this important? Vasectomies are typically done with local anesthesia (pain relief), but many patients still feel anxiety or discomfort. VR may help distract and relax patients, improving their experience. This study will help health professionals understand if VR could be a useful option for future patients.

Conditions

Interventions

DEVICE

Virtual reality (VR) guided meditation therapy

Participants will engage in the TRIPP relaxation app on the MetaQuest 3 VR headset.

OTHER

Treatment as usual

Participants undergo a standard vasectomy.

Sponsors & Collaborators

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Renée El-Gabalawy, MA, PhD, C. Psych · University of Manitoba

  • Premal Patel, MD, FRCSC · Manitoba Men's Health Clinic

  • Ahmed M Zalam, B.Sc. · University of Manitoba

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-02
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07055178 on ClinicalTrials.gov